Denali Therapeutics Inc.
(DNLI)
undefined
undefined%
At close: undefined
22.97
0.04%
After-hours Dec 13, 2024, 04:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Revenue | 330.53M | 108.46M | 48.66M | 335.66M | 26.68M | 129.16M | - | - | - |
Cost of Revenue | 16.73M | 7.03M | 5.61M | 212.62M | 193.38M | 7.42M | 3.08M | 1.47M | 121.00K |
Gross Profit | 313.81M | 101.43M | 43.05M | 123.04M | -166.70M | 121.75M | -3.08M | -1.47M | -121.00K |
Operating Income | -196.70M | -340.74M | -295.75M | 62.72M | -213.18M | -46.37M | -90.14M | -87.43M | -16.68M |
Interest Income | 51.51M | 14.77M | 4.59M | 9.14M | 15.22M | 10.13M | 1.96M | 781.00K | - |
Pretax Income | -145.19M | -325.97M | -291.16M | 71.96M | -197.97M | -36.24M | -88.19M | -86.65M | -16.79M |
Net Income | -145.22M | -325.99M | -290.58M | 71.14M | -197.61M | -36.24M | -88.19M | -86.65M | -16.79M |
Selling & General & Admin | 103.35M | 90.47M | 79.06M | 60.33M | 46.48M | 32.35M | 15.68M | 11.73M | 5.11M |
Research & Development | 423.88M | 358.73M | 265.35M | 212.62M | 193.38M | 143.18M | 74.46M | 75.70M | 11.57M |
Other Expenses | - | - | - | - | - | - | - | - | - |
Operating Expenses | 527.23M | 449.21M | 344.41M | 272.94M | 239.86M | 175.53M | 90.14M | 87.43M | 16.68M |
Interest Expense | - | 14.77M | - | - | 15.22M | - | 1.96M | - | 109.00K |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 527.23M | 449.21M | 344.41M | 272.94M | 239.86M | 175.53M | 90.14M | 87.43M | 16.68M |
Income Tax | 30.00K | 21.00K | -575.00K | 823.00K | -351.00K | 10.13M | -3.08M | - | - |
Shares Outstanding (Basic) | 137.37M | 125.53M | 121.52M | 108.97M | 95.61M | 92.62M | 14.96M | 6.42M | 3.01M |
Shares Outstanding (Diluted) | 137.37M | 125.53M | 121.52M | 112.70M | 95.61M | 92.62M | 14.96M | 6.42M | 3.01M |
EPS (Basic) | -1.06 | -2.6 | -2.39 | 0.65 | -2.07 | -0.39 | -5.89 | -13.49 | -5.58 |
EPS (Diluted) | -1.06 | -2.6 | -2.39 | 0.63 | -2.07 | -0.39 | -5.89 | -13.49 | -5.58 |
EBITDA | -179.97M | -330.36M | -287.16M | 62.72M | -205.19M | -38.96M | -87.06M | -85.96M | -15.06M |
Depreciation & Amortization | 16.73M | 7.03M | 5.61M | 6.17M | 7.99M | 7.42M | 3.08M | 1.47M | 121.00K |